Hepatitis B reactivation related to everolimus

doi:10.4254/wjh.v5.i1.43

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5852)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

494

HTML

3475

Figures (1-1)

320

Sum=4289

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

988

Download

575

Sum=1563

Jan 27, 2013 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Hepatol. Jan 27, 2013; 5(1): 43-45
Published online Jan 27, 2013. doi: 10.4254/wjh.v5.i1.43

Open in New Tab Full Size Figure Download Figure

Figure 1 Serum transaminase (A) and bilirubin (B) levels of the hepatitis B virus reactivation patient. Everolimus treatment was initiated in January, 2012. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; DB: Direct bilirubin; TB: Total bilirubin.

Citation: Sezgin Göksu S, Bilal Ş, Coşkun HŞ. Hepatitis B reactivation related to everolimus. World J Hepatol 2013; 5(1): 43-45
URL: https://www.wjgnet.com/1948-5182/full/v5/i1/43.htm
DOI: https://dx.doi.org/10.4254/wjh.v5.i1.43